Citing ‘clear scientific evidence,’ AZ seeks to reassure jittery Europe on vaccine’s safety 

Germany is the latest EU country to suspend the rollout of COVID-19 Vaccine AstraZeneca amid concerns over thromboembolic events even as the U.K. pharma contends “clear scientific evidence” that the numbers are in line with the expected background rate of such events and EMA says there is no evidence of a link between the events and the product.

More than 17 million people have been vaccinated with the vaccine across the EU and U.K., according to AstraZeneca plc (LSE:AZN; NASDAQ:AZN), which said Sunday that the 15 reported cases of deep vein thrombosis (DVT) and 22 cases of pulmonary embolism equate to a “much lower” event rate than what would be expected in the general population. ...